Vir Biotechnology (VIR) FCF Margin Growth (3y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 10,029.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 723.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1,409.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 6,066.00 |
| 10 | Vir Biotechnology | 1.33 Bn | 1.33 Bn | - | -45.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.76 Mn |
| Dec 31, 2025 | -8,657.00 |
| Sep 30, 2025 | -7.00 Mn |
| Jun 30, 2025 | -1.24 Mn |
| Mar 31, 2025 | -267,346.00 |
| Dec 31, 2024 | -72,368.00 |
| Sep 30, 2024 | -721,318.00 |
| Jun 30, 2024 | -263,524.00 |
| Mar 31, 2024 | 433,474.00 |
| Dec 31, 2023 | 422,002.00 |
| Sep 30, 2023 | -338,402.00 |
| Jun 30, 2023 | -1.05 Mn |
| Mar 31, 2023 | 64,502.00 |
| Dec 31, 2022 | 408,411.00 |
| Sep 30, 2022 | 223,767.00 |
| Jun 30, 2022 | 362,943.00 |
| Mar 31, 2022 | 94,379.00 |
| Dec 31, 2021 | 119,329.00 |